MMR Vaccine Safety and Vaccine Injury Compensation: What Rare Injury Cases Do and Don’t Tell Us

In 2007, a special master of the U.S. Court of Federal Claims ruled in favor of the family of a child named Bailey Banks, finding that his measles, mumps, and rubella (MMR) vaccination had more likely than not caused a brain inflammation called acute disseminated encephalomyelitis, or ADEM, which led to developmental delays. The decision was later shared online as proof that the government had admitted the MMR vaccine causes autism, and that the story had been ignored.

The case is real, and the injury the family experienced was real. But the decision did not find that MMR causes autism, and it does not show what many posts claim. Understanding why requires understanding how the U.S. vaccine injury compensation system works, what rare injuries the MMR vaccine can cause, and what large studies show about autism. This article covers all three, along with why the question matters urgently in 2026, as measles has returned to the United States at levels not seen in more than three decades.

How Vaccine Injury Compensation Works

In the 1980s, lawsuits over alleged vaccine injuries led some manufacturers to leave the U.S. vaccine market, threatening supply. Congress responded with the National Childhood Vaccine Injury Act of 1986, which created the National Vaccine Injury Compensation Program (VICP), administered by the Health Resources and Services Administration. The program began accepting claims in 1988.

The VICP is designed to be a no-fault alternative to traditional lawsuits. Claimants file petitions in the U.S. Court of Federal Claims, where specialized judges called special masters decide cases. The program is funded by an excise tax on each dose of covered vaccines, not by general taxpayer funds. Its key features include:

The Vaccine Injury Table. For certain injuries that occur within specified time frames after specific vaccines, causation is presumed. If a child develops a table injury within the listed window, the claimant does not have to prove the vaccine caused it, unless the government shows another cause.

Off-table claims. Claimants can also seek compensation for injuries not on the table, but must show by a preponderance of the evidence, meaning more likely than not, that the vaccine caused the injury, typically by offering a medical theory, a logical sequence of cause and effect, and an appropriate timing.

Settlements. Many compensated cases are resolved through negotiated settlements in which the government does not concede that the vaccine caused the injury, which allows faster payment to families.

According to HRSA, the program has paid billions of dollars in compensation since 1988. HRSA also reports that, for vaccines covered by the program, roughly one person has been compensated for every million doses distributed in recent years, a rate that includes settlements without findings of causation.

What the Bailey Banks Decision Found

The Banks petition argued that the child’s MMR vaccination caused ADEM, an inflammatory condition of the brain and spinal cord that can follow infections and, rarely, vaccinations, and that the ADEM in turn caused his developmental problems. In 2007, the special master found that the family had shown, under the program’s legal standard, that the vaccine more likely than not caused ADEM in this child, and that the ADEM caused his developmental delay. The family was awarded compensation.

Several points about the case are important:

It was about ADEM. The decision rested on evidence that the child had a specific inflammatory brain injury. It did not find that MMR causes autism in general or that it caused classic autism in this child.

It applied a legal, not scientific, standard. Special masters decide whether a claimant’s case is more likely than not, in an individual case. That is a lower and different bar than the scientific standard required to conclude that a vaccine causes a condition across populations.

It was not hidden. VICP decisions are generally published, and this case was discussed publicly at the time.

A few other VICP cases have similarly compensated children who developed an encephalopathy or other injury after vaccination and later showed autism-like symptoms. Those decisions turned on evidence of a specific injury in a specific child.

The Autism Omnibus Proceeding

By the mid-2000s, more than 5,000 families had filed VICP claims alleging that vaccines caused their children’s autism. The court consolidated them into the Omnibus Autism Proceeding, in which test cases were heard on behalf of the larger group. Petitioners presented two main theories: that MMR combined with thimerosal-containing vaccines caused autism, and that thimerosal-containing vaccines alone did.

After extensive hearings with expert testimony, special masters ruled against the petitioners in all test cases, in 2009 for the combined MMR-thimerosal theory and in 2010 for the thimerosal-only theory, finding that the evidence did not support either theory. The decisions were upheld on appeal. The Omnibus decisions remain the court’s most comprehensive examination of the autism question.

Known Side Effects of the MMR Vaccine

Like any medical intervention, the MMR vaccine can cause side effects. Most are mild and short-lived. The U.S. Centers for Disease Control and Prevention lists the following approximate frequencies after MMR vaccination: fever in up to about 1 in 6 people; mild rash in about 1 in 20; temporary swelling of glands in the cheeks or neck in about 1 in 75; temporary joint pain and stiffness, mostly in teenage or adult women, in up to about 1 in 4 of them; febrile seizures, usually in young children and without lasting harm, in about 1 in 3,000 to 4,000 doses; temporarily low platelet count, which can cause bleeding but usually resolves, in about 1 in 30,000 to 40,000 doses; and severe allergic reactions in about 1 in a million doses. Brain inflammation such as encephalitis or ADEM after MMR is extremely rare, so rare that it is difficult to establish a precise rate.

Some MMR reactions appear on the federal Vaccine Injury Table, which presumes causation for compensation purposes when they occur in specified time windows. These include severe allergic reactions within hours of vaccination, encephalopathy or encephalitis within roughly 5 to 15 days, chronic arthritis after the rubella component, thrombocytopenic purpura, and vaccine-strain measles infection in people with weakened immune systems. Autism is not on the table.

What Research Shows About MMR and Autism

The concern that MMR causes autism began with a 1998 paper in The Lancet by Andrew Wakefield and colleagues, describing 12 children with developmental and bowel problems and suggesting a possible link to MMR vaccination. Investigations later found serious problems with the research, including undisclosed financial conflicts and misrepresentation of children’s histories. The Lancet fully retracted the paper in 2010, and Wakefield lost his medical license in the United Kingdom.

In the years since, many large studies have examined the question:

A 2019 nationwide cohort study in the Annals of Internal Medicine by Anders Hviid and colleagues followed 657,461 children born in Denmark from 1999 through 2010. Comparing vaccinated and unvaccinated children, the study found an autism hazard ratio of 0.93 (95% confidence interval 0.85 to 1.02), meaning no increased risk. There was also no increased risk in subgroups, including children with siblings with autism or other autism risk factors, and no clustering of autism diagnoses after vaccination.

A 2014 meta-analysis in Vaccine by Luke Taylor and colleagues pooled cohort and case-control studies involving more than a million children and found no association between vaccination, including MMR, and autism.

A 2021 Cochrane systematic review of vaccines for measles, mumps, rubella, and varicella, examining dozens of studies covering millions of children, found no evidence of an association between MMR vaccination and autism, while confirming the vaccine’s effectiveness and noting the rare risk of febrile seizures and low platelets.

Why Autism Signs Can Appear After Vaccination

Parents who notice autism signs soon after a vaccination understandably wonder whether the two are connected. The timing has a well-understood explanation. The MMR vaccine is typically given at 12 to 15 months of age, which is also when signs of autism often become noticeable, as children are expected to develop language and social communication skills. Many children who are later diagnosed with autism show subtle differences earlier, and research using home videos and prospective studies of infants at high risk has found that brain and behavioral differences can be present before the first birthday. When two common events happen at the same age, some will coincide by chance. Large population studies are designed to separate coincidence from cause, and they consistently find no causal link.

Measles Is Back, and It Is Dangerous

The question of MMR safety is not academic. After measles was declared eliminated in the United States in 2000, annual case counts usually stayed in the dozens to low hundreds. That changed in 2025, when an outbreak that began in an undervaccinated community in West Texas spread to other states. The CDC’s final count for 2025 was about 2,288 confirmed cases, the most since 1991, with three deaths, the first U.S. measles deaths in a decade, including two unvaccinated school-age children in Texas. About 92 percent of cases occurred in people who were unvaccinated or whose vaccination status was unknown.

Transmission continued into 2026. According to the Johns Hopkins measles tracker, the United States had recorded 2,295 confirmed cases by July 21, 2026, surpassing the entire 2025 total. The Region of the Americas lost its regional measles elimination status in late 2025 after transmission was re-established in Canada, and the U.S. status is scheduled for review by the Pan American Health Organization in November 2026.

Measles is one of the most contagious diseases known; one infected person can spread it to up to nine out of ten unprotected close contacts. The World Health Organization notes that complications can include severe pneumonia, encephalitis, blindness, severe diarrhea, and death, with young children and malnourished or immunocompromised people at greatest risk. About 1 in 5 unvaccinated people in the United States who get measles is hospitalized. Measles encephalitis occurs in roughly 1 in 1,000 cases, and a rare fatal brain disease called subacute sclerosing panencephalitis can appear years after infection. Measles can also weaken the immune system’s memory of previous infections, leaving children more vulnerable to other diseases for months or years.

The MMR vaccine is highly effective: according to the CDC, one dose is about 93 percent effective against measles and two doses about 97 percent.

Outcome	After measles infection	After MMR vaccination
Hospitalization	About 1 in 5 unvaccinated U.S. cases	Rare
Brain inflammation	Encephalitis about 1 in 1,000 cases	Extremely rare; too rare to estimate precisely
Low platelets	Can occur with infection	About 1 in 30,000–40,000 doses, usually temporary
Febrile seizures	Common with high fever	About 1 in 3,000–4,000 doses, usually without lasting harm
Death	Occurs; 3 U.S. deaths in 2025	Not a recognized outcome in healthy recipients

Measles Before the Vaccine

It is easy to forget how common and serious measles once was. Before a measles vaccine became available in the United States in 1963, nearly every child caught measles by age 15. The CDC estimates that each year in that era, about 3 to 4 million people in the U.S. were infected, around 48,000 were hospitalized, about 1,000 developed encephalitis, and roughly 400 to 500 died. Widespread vaccination, later with the combined MMR vaccine and a two-dose schedule, drove cases down by more than 99 percent and led to the declaration of measles elimination in 2000, meaning the disease was no longer continuously spreading within the country.

That history explains why public health experts view recent outbreaks with alarm. The vaccine did not make measles less dangerous; it made it rare. When vaccination rates fall in a community, the disease returns with the same capacity to cause harm.

Who Should and Should Not Get MMR

The routine schedule. In the United States, children are recommended to receive two doses of MMR: the first at 12 to 15 months of age and the second at 4 to 6 years. Infants aged 6 to 11 months should receive an early dose before international travel or in some outbreak settings, followed by the routine doses later. Adults born in 1957 or later who lack evidence of immunity should receive at least one dose, and some adults, such as healthcare workers, college students, and international travelers, should have two.

Who should not receive MMR. People who have had a severe allergic reaction to a previous dose or to a vaccine component, such as gelatin or the antibiotic neomycin, should not receive it. Because MMR is a live attenuated vaccine, it is not given during pregnancy, and people are advised to avoid becoming pregnant for four weeks after vaccination. People with severely weakened immune systems, for example from certain cancers, treatments, or advanced HIV infection, generally should not receive it.

Precautions. People with moderate or severe acute illness may be advised to wait until they recover. Those who have recently received blood products, or who have a history of low platelet counts, should discuss timing with their healthcare provider.

Egg allergy is not a reason to avoid MMR. Although the measles and mumps components are grown in chick embryo cell cultures, people with egg allergy, even severe, can receive MMR safely according to current guidance.

Talking With Your Child’s Doctor

Parents with concerns about vaccines are not unusual, and pediatricians expect questions. Productive conversations often start with specific concerns: a story read online, a family history of reactions, or uncertainty about the schedule. Useful questions include: What side effects should I watch for, and when should I call? Does my child have any condition that changes the recommendation? What are the risks of delaying? How common is measles in our area right now?

Bringing the specific article or story that prompted concern can help the clinician address it directly. If a child has had an unusual reaction to a previous vaccine, the clinician can review it, report it to VAERS if appropriate, and, if needed, refer the family to a specialist in vaccine safety or allergy.

Reporting and Monitoring Vaccine Reactions

The United States uses several systems to monitor vaccine safety. The Vaccine Adverse Event Reporting System (VAERS) accepts reports of health problems after vaccination from anyone, including parents and healthcare providers. VAERS reports alone cannot establish causation, since anyone can report and events may be coincidental, but they help detect possible signals for further investigation. The Vaccine Safety Datalink, a collaboration between the CDC and health systems, uses medical records from millions of patients to study whether specific problems occur more often after vaccination. Clinical immunization safety assessment networks help evaluate complex cases.

Families who believe their child was injured by a vaccine can report the event to VAERS, discuss it with their healthcare provider, and learn about filing a VICP claim, which generally must be filed within three years of the first symptom.

Respecting Families While Following the Evidence

Stories like the Banks case often spread because they speak to parents’ deepest fears and to real experiences of children who became seriously ill. A respectful response acknowledges that rare vaccine injuries do happen, that the compensation program exists precisely because society asks families to vaccinate for the common good, and that families harmed deserve support. It also recognizes that the evidence from millions of children consistently shows MMR does not cause autism, and that measles poses far greater risks than the vaccine. Holding both truths at once is the basis for trust.

What the Compensation Program Covers

The VICP covers vaccines routinely recommended for children or pregnant women that are subject to the federal excise tax, including MMR. It can compensate for medical and rehabilitation costs not covered by insurance, lost earnings, pain and suffering up to a statutory limit, and, in cases of death, a death benefit, along with reasonable attorneys’ fees, which the program pays even when claims are unsuccessful if they were brought in good faith. This fee provision is intended to ensure families can obtain legal help.

The program’s existence is sometimes cited as proof that vaccines are dangerous. In fact, it reflects a policy choice: because society recommends vaccines for the benefit of individuals and communities, it provides a simpler path to compensation for the rare people who are harmed, while protecting the vaccine supply. Compensation decisions, especially settlements, are not findings that vaccines commonly cause a particular injury.

Why Vaccination Rates Matter for Everyone

Because measles is so contagious, preventing outbreaks requires very high vaccination coverage, generally estimated at about 95 percent with two doses. When coverage falls below that level in a school or community, measles can spread once introduced, often by a traveler. The people most at risk in an outbreak include infants too young to be vaccinated, people with medical conditions that prevent vaccination, and those whose immune systems are weakened by illness or treatment. High community vaccination rates protect these vulnerable people by preventing the virus from circulating.

National averages can hide local gaps. Even when overall U.S. coverage looks high, clusters of undervaccinated communities, schools with many exemptions, or close-knit groups can sustain outbreaks, as the 2025 West Texas outbreak demonstrated. Public health officials therefore pay close attention to local coverage data and to making vaccination accessible and trusted in every community.

Common Myths About MMR

“Vaccine court proved MMR causes autism.” The court’s Autism Omnibus test cases rejected that theory. Individual compensated cases involved specific injuries such as encephalopathy, decided under a legal standard.

“Measles is a mild childhood illness.” Many cases are uncomplicated, but measles can cause pneumonia, encephalitis, and death; about 1 in 5 unvaccinated U.S. patients is hospitalized.

“Natural immunity is better.” Measles infection does produce lasting immunity, but at the cost of the disease’s risks, including the possibility of losing immune memory to other infections.

“Splitting MMR into separate shots is safer.” There is no evidence that separate vaccines are safer, and spacing them out leaves children unprotected for longer. Separate measles, mumps, and rubella vaccines are not available in the United States.

“Vaccine ingredients are toxic.” Ingredients are present in very small amounts that have been evaluated for safety; the dose determines toxicity.

“Outbreaks happen mostly among vaccinated people.” In the 2025 U.S. outbreaks, about 92 percent of cases were in people who were unvaccinated or whose status was unknown.

Key Terms

VICP: National Vaccine Injury Compensation Program, the federal no-fault system for vaccine injury claims.

Special master: A judicial officer of the U.S. Court of Federal Claims who decides VICP cases.

Vaccine Injury Table: A list of injuries presumed to be caused by specific vaccines if they occur within set time frames.

ADEM: Acute disseminated encephalomyelitis, a rare inflammatory condition of the brain and spinal cord.

VAERS: Vaccine Adverse Event Reporting System, a national early-warning system for possible vaccine safety problems.

Elimination: The absence of continuous disease transmission in a country for 12 months or more.

If Your Child Has a Reaction

Most reactions after MMR are mild and resolve on their own. Fever and rash typically appear about a week to 12 days after vaccination, when the weakened vaccine viruses are replicating, and usually last a few days. Fever can be managed with age-appropriate fever reducers and fluids. Parents should seek immediate care for signs of a severe allergic reaction, such as hives, swelling of the face or throat, difficulty breathing, a fast heartbeat, or weakness, which usually occur within minutes to hours. They should also contact a healthcare provider for a seizure, unusual bruising or bleeding, high fever, or any symptom that seems serious. After any significant reaction, families can ask their provider to report it to VAERS or report it themselves, and discuss whether future doses should be modified.

The Bottom Line

The Bailey Banks case is a reminder that rare vaccine injuries are real and that the compensation program exists to support families when they happen. But the case concerned a specific brain inflammation, decided under a legal standard, not a finding that MMR causes autism. Studies of hundreds of thousands to millions of children consistently show no link between MMR and autism, while measles, now resurging in the United States, causes hospitalizations, brain inflammation, and deaths. For nearly all children and adults, the benefits of MMR vaccination far outweigh its small risks.

Frequently Asked Questions

Did the government admit that MMR causes autism in the Bailey Banks case?

No. The 2007 decision found, under the program’s legal standard, that MMR more likely than not caused ADEM, a brain inflammation, in one child, which led to developmental delays. It did not find that MMR causes autism generally.

What is the Vaccine Injury Compensation Program?

A federal no-fault program created in 1986 that compensates people injured by covered vaccines, funded by an excise tax on vaccines. Many cases are settled without a finding that the vaccine caused the injury.

Does the MMR vaccine cause autism?

No. Large studies, including one of 657,461 Danish children and a Cochrane review covering millions of children, found no association. The 1998 study that suggested a link was retracted.

What are the real risks of the MMR vaccine?

Most side effects are mild, such as fever or rash. Rare serious effects include febrile seizures, temporary low platelets, and, very rarely, severe allergic reactions.

How many measles cases has the U.S. had recently?

About 2,288 in 2025, the most since 1991, with three deaths, and more than 2,295 by late July 2026.

How effective is the MMR vaccine?

About 93 percent effective against measles after one dose and 97 percent after two.

References

1. Health Resources and Services Administration. National Vaccine Injury Compensation Program. hrsa.gov
2. Hviid A, Hansen JV, Frisch M, Melbye M. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. Annals of Internal Medicine. 2019;170(8):513–520. PMID 30831578
3. Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32(29):3623–3629. PMID 24814559
4. Di Pietrantonj C, Rivetti A, Marchione P, et al. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database of Systematic Reviews. 2021;11:CD004407. PMID 34806766
5. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103):637–641 (retracted). PMID 9500320
6. The Editors of The Lancet. Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 2010;375(9713):445. PMID 20137807
7. Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center. 2026 U.S. Measles Cases Surpass 2025 Level. July 2026. publichealth.jhu.edu
8. World Health Organization. Measles fact sheet. who.int

Last updated: October 1, 2026